8-K/AThe WireRoutine
Shareholder Vote
Filed Jul 7, 2017 · 9y ago · Accession 0001628280-17-006957
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- 8-K/A
- Filing date
- Jul 7, 2017
- Report date
- Jun 30, 2017
- Document
- cerecor-form8xkannualmeeti.htm
- Size
- 48 KB